Skip to Main Content

Author Details

Peter T Frame
University of Michigan ann arbor
1976
49
30
PMIDPaper TitleJournal TitlePublished Year
37561774Space-time POD and the Hankel matrix.PLoS One2023
18090057A truvada hypersensitivity reaction simulating abacavir hypersensitivity.AIDS2007
15988422Emergency department HIV testing and counseling: an ongoing experience in a low-prevalence area.Ann Emerg Med2005
16134565Health department collaboration with emergency departments as a model for public health programs among at-risk populations.Public Health Rep2005
12825257HIV disease in primary care.Prim Care2003
11839141Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection.AIDS Res Hum Retroviruses2002
11372024Role of CD40 ligand signaling in defective type 1 cytokine response in human immunodeficiency virus infection.J Infect Dis2001
10710206A randomized trial of interferon alpha therapy for HIV type 1 infection.AIDS Res Hum Retroviruses2000
10816143Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.Clin Infect Dis2000
9203650Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease.J Infect Dis1997
8610948Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.Ann Intern Med1996
8853724Serum chemokine levels in patients with non-progressing HIV infection.AIDS1996
7844367Macrophages from human immunodeficiency virus-positive persons are defective in host defense against Histoplasma capsulatum.J Infect Dis1995
7854375A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.N Engl J Med1995
7854376A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.N Engl J Med1995
7531457Analysis of Pneumocystis carinii organism burden, viability and antigens in bronchoalveolar lavage fluid in AIDS patients with pneumocystosis: correlation with disease severity.AIDS1994
8086134Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity.AIDS1994
8014493Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031.J Infect Dis1994
7985710The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients.Am J Med1994
7979286Pharmacokinetics of zidovudine phosphorylation in peripheral blood mononuclear cells from patients infected with human immunodeficiency virus.Antimicrob Agents Chemother1994
8097082Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy.Ann Intern Med1993
8479489Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.N Engl J Med1993
8432132Increased Pneumocystis carinii recovery from the upper lobes in Pneumocystis pneumonia. The effect of aerosol pentamidine prophylaxis.Chest1993
1448121A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.N Engl J Med1992
1586072Detection of cryptococcal antigen in bronchoalveolar lavage fluid: a prospective study of diagnostic utility.Am Rev Respir Dis1992
1519301Pharmacokinetics of zidovudine phosphorylation in patients infected with the human immunodeficiency virus.Ther Drug Monit1992
1780965Concentrations of phosphorylated zidovudine (ZDV) in patient leukocytes do not correlate with ZDV dose or plasma concentrations.Ther Drug Monit1991
1898648Bronchoscopy with bronchoalveolar lavage in tuberculosis and fungal infections.Chest1991
1818178Open-label efficacy and safety trial of 42 days of 566C80 for Pneumocystis carinii pneumonia in AIDS patients.J Protozool1991
1818161Generalized immune response to Pneumocystis carinii infection in the lung.J Protozool1991
1708950Follow-up bronchoalveolar lavage in AIDS patients with Pneumocystis carinii pneumonia. Pneumocystis carinii burden predicts early relapse.Am Rev Respir Dis1991
2380366Semiquantitative technique for estimating Pneumocystis carinii burden in the lung.J Clin Microbiol1990
2476103The use of an indirect fluorescent antibody test for detecting Pneumocystis carinii.Arch Pathol Lab Med1989
2801730Histoplasma capsulatum polysaccharide antigen detection in diagnosis and management of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome.Am J Med1989
2500312Recovery of human immunodeficiency virus and detection of p24 antigen in bronchoalveolar lavage fluid from adult patients with AIDS.Chest1989
2952062Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections.Antimicrob Agents Chemother1987
3802934Use of the protected specimen brush in patients with endotracheal or tracheostomy tubes.Chest1987
3559289Bronchoalveolar lavage for diagnosing acute bacterial pneumonia.J Infect Dis1987
3602797Treatment of infections of cerebrospinal fluid shunts.Rev Infect Dis1987
2878246Azidothymidine neurotoxicity.Lancet1986
6607326Treatment of CSF shunt infections with intrashunt plus oral antibiotic therapy.J Neurosurg1984
6835496Penetration of nafcillin, methicillin, and cefazolin into human brain tissue.Neurosurgery1983
7087132Outpatient intravenous antibiotic therapy.JAMA1982
7023228Infection of bone by Mycobacterium fortuitum masquerading as Nocardia asteroides.Am J Clin Pathol1981
7247593Invasive fungal infections in patients with chronic mucocutaneous candidiasis.Arch Intern Med1981
18748423Treatment of Legionnaire's Disease.West J Med1979
848928Bone marrow toxicity associated with 5-fluorocytosine therapy.Antimicrob Agents Chemother1977
864290Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits.J Infect Dis1977
769677Simple assay for 5-fluorocytosine in the presence of amphotericin B.Antimicrob Agents Chemother1976
  • 1 - 49 of 49

Recommended Authors

Emory University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
University of Kansas Medical Center
Career Start Year 2006
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 0
Federal University of Rio de Janeiro
Career Start Year 1998
Number of shared co-authors 1
Emory University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1993
Number of shared co-authors 0
Hospital Chemnitz
Career Start Year 1991
Number of shared co-authors 0
Cincinnati Children's Hospital
Career Start Year 1989
Number of shared co-authors 2
Mount Sinai Health System and University Health Network
Career Start Year 1989
Number of shared co-authors 0
University Medical Center Utrecht
Career Start Year 1988
Number of shared co-authors 1
Hospital Universitario Ramon y Cajal
Career Start Year 1988
Number of shared co-authors 0
University of Massachusetts Medical School-Baystate
Career Start Year 1988
Number of shared co-authors 5
VA Medical Center
Career Start Year 1986
Number of shared co-authors 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 1
Feinberg School of Medicine, Northwestern University
Career Start Year 1984
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 3
Perelman School of Medicine, the University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 1
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 0
University of Toronto, and University Health Network, Toronto General Hospital
Career Start Year 1982
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1981
Number of shared co-authors 0
David Geffen School of Medicine at university of california los angeles
Career Start Year 1981
Number of shared co-authors 0
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 0
Medical University of South Carolina
Career Start Year 1981
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 1979
Number of shared co-authors 1
Dalhousie University
Career Start Year 1977
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 1975
Number of shared co-authors 0
University of California San Diego
Career Start Year 1975
Number of shared co-authors 2
Howard Levy Consulting LLC
Career Start Year 1966
Number of shared co-authors 0
University of Manitoba
Career Start Year 1965
Number of shared co-authors 0
University of Florida Health
Career Start Year 1961
Number of shared co-authors 0

Collaborators

Harvard Medical School
Co-authored papers 5
Co-authored papers 3
Duke University
Co-authored papers 2
University of Utah
Co-authored papers 2
University of Cincinnati
Co-authored papers 2
The Ohio State University College of Medicine
Co-authored papers 2
University of Cincinnati College of Medicine
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Adjunct professor and IRB chair at the University of Cincinnati College of Medicine.
Co-authored papers 1
Co-authored papers 1